1. Blockade of osteopontin reduces alloreactive CD8 + T cell– mediated graft-versus-host disease by Fang Zhao, Yi Zhang, Hao Wang, Min Jin, Shan He, Yufang Shi, Yajun Guo, and Yanyun Zhang Blood Volume 117(5):1723-1733 February 3, 2011 ©2011 by American Society of Hematology

2. Expression of OPN during GVHD. Lethally irradiated B6/SJL recipient mice (CD45.1+) were injected with C3H.SW CD8+ T cells (CD45.2+, 2 × 106) plus C3H.SW TCD BM (5 × 106) or C3H.SW TCD BM (5 × 106) alone. Fang Zhao et al. Blood 2011;117:1723-1733 ©2011 by American Society of Hematology

3. Inhibition of CD8+ T cell-mediated GVHD by anti-OPN Ab. Lethally irradiated B6/SJL recipient mice were injected with C3H.SW CD8+ T cells plus C3H.SW TCD BM or C3H.SW TCD BM alone. Fang Zhao et al. Blood 2011;117:1723-1733 ©2011 by American Society of Hematology

4. Anti-OPN treatment reduces persistence of donor T cells in recipient tissues. Fang Zhao et al. Blood 2011;117:1723-1733 ©2011 by American Society of Hematology

5. Effect of OPN on migration of donor-derived CD8+ T cells. Fang Zhao et al. Blood 2011;117:1723-1733 ©2011 by American Society of Hematology

6. Anti-OPN Ab reduces donor T-cell survival. Fang Zhao et al. Blood 2011;117:1723-1733 ©2011 by American Society of Hematology

7. Effects of OPN on T-cell activation. Fang Zhao et al. Blood 2011;117:1723-1733 ©2011 by American Society of Hematology

8. Maintenance of GVL on anti-OPN treatment. Fang Zhao et al. Blood 2011;117:1723-1733 ©2011 by American Society of Hematology